Oncologists’ consideration of Health related quality of life in clinical practice for Immune-Checkpoint Inhibitors-treated patients: an online patients community research

2020-09-02T09:43:57+00:00 August 18th, 2020|Featured, Publications|

  • Presented at the European Society for Medical Oncology Immuno-Oncology Congress 2019

  • Collaborator: Bristol-Myers Squibb France

  • Authors: Ophélie Wilczynski, Anthony Boisbouvier, Lise Radoszycki, François-Emery Cotte, Anne-Françoise Gaudin, Hervé Lemasson

Preserving the health related quality of life (HRQoL) of cancer patients is a major goal of clinicians and health authorities. Routine monitoring of PROs in daily clinical practice has demonstrated improvements in symptom management, patient satisfaction with care, levels of supportive care use, clinician/patient communication, HRQoL and overall survival. The study objective was to describe patients’ experience and expectations regarding HRQoL, in particular in their relationship with oncologists/radiotherapists.